An intensive model of care for hepatitis C virus screening and treatment with direct‐acting antivirals in people who inject drugs in Nairobi, Kenya: a model‐based cost‐effectiveness analysis.

Background and aims: Hepatitis C virus (HCV) treatment is essential for eliminating HCV in people who inject drugs (PWID), but has limited coverage in resource‐limited settings. We measured the cost‐effectiveness of a pilot HCV screening and treatment intervention using directly observed therapy amo...

Descripción completa

Detalles Bibliográficos

Publicado en:	Addiction Vol. 117; no. 2; pp. 411 - 425
Autores principales:	Mafirakureva, Nyashadzaishe, Stone, Jack, Fraser, Hannah, Nzomukunda, Yvonne, Maina, Aron, Thiong'o, Angela W., Kizito, Kibango Walter, Mucara, Esther W. K., González Diaz, C. Inés, Musyoki, Helgar, Mundia, Bernard, Cherutich, Peter, Nyakowa, Mercy, Lizcano, John, Chhun, Nok, Kurth, Ann, Akiyama, Matthew J., Waruiru, Wanjiru, Bhattacharjee, Parinita, Cleland, Charles
Formato:	research tables/charts Journal Article
Publicado:	Wiley-Blackwell Feb2022
Acceso en línea:	Ver este registro en EBSCOhost